TCL Archive Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote July 2, 1999
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive In Brief Election Results Won’t Hurt Cancer Program, May Help; Coper To Stay If Carter Wants Him November 12, 1976